Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SHP-2 is a cytoplasmic protein tyrosine phosphatase that plays a critical role in multiple cellular signaling pathways. It regulates cell growth, differentiation, survival, and immune responses by dephosphorylating specific substrates involved in signal transduction cascades. Mutations in SHP-2 are implicated in several human diseases, including Noonan syndrome, LEOPARD syndrome, and juvenile myelomonocytic leukemia.
Dephosphorylation of target proteins after recruitment via pY-binding through its two SH2 domains, modulating downstream signaling cascades.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Src Homology Region 2-Containing Protein Tyrosine Phosphatase (SHP-2).